Companies category powered by

Experience the Marex 310 Sun Cruiser with SwissClub Marine’s co-ownership programme

You can now co-own a €400,000 Marex 310 Sun Cruiser yacht by investing just €50,000 and enjoying 45 days a year at sea, with SwissClub Marine’s 8-year Co-Ownership Programme.

In total, the co-owners get to enjoy 360 days of hassle-free yachting over a period of eight years, whether they opt for sun drenched summers or serene off-seasons cruises.

Meanwhile, the Estimated Resale Price of the yacht may reduce daily yachting costs to as low as €70. All maintenance, berthing and cleaning is professionally and competitively managed by SwissClub Marine, with the cost shared between the co-owners.

The co-owners share in the proceeds from the eventual sale of the Yacht.

The Marex 310 Sun Cruiser, renowned for its design, craftsmanship and seaworthiness, offers an unparalleled boating experience. The international award winning yacht comes with two cabins and a 2 x Bravo3 Mercury engine, as well as a huge list of standard equipment.

Subject to Terms & Conditions. Prices are subject to confirmation & exclude running costs.

For further information, visit www.swissclubmarine.com or call +357 22 330 050

Read More

CPI Holdings Plc announces definitive agreement for the acquisition of SCSS Fund Management Ltd
The deadline is almost here: Submit your nominations now for the CBN Young Dragon Awards!
Limassol-based Nexters’ ‘Hero Wars: Alliance’ clears $1.5 billion in revenue
payabl. partners with KidIT Cyprus and AEL Limassol Basketball Club for an exciting end-of-term celebration
Bank of Cyprus becomes founding financier in the 33East Investment Fund with a €2m investment
Companies in Cyprus deeply concerned about corruption, European Commission report suggests
Hermes Airports installs additional water fountain points at Larnaka and Pafos Airports (video)
Deadline for CBN Young Dragon Awards draws closer
Find Me Falling: Njoy Radio's cameo in first Cypriot film on Netflix (video)
ILIKOS Consulting Group and Phoenix Clinical Research announce strategic partnership